Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Haeuser, Friederike; Mittler, Jens; Hantal, Misra Simge et al.

One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023


Hartmann, Ann-Kathrin; Bartneck, Joschka; Pielenhofer, Jonas et al.

Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection

FRONTIERS IN IMMUNOLOGY. Bd. 14. 2023


Schubert, Maria-Luisa; Bethge, Wolfgang A.; Ayuk, Francis A. et al.

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

BLOOD ADVANCES. Bd. 7. H. 20. 2023 S. 6191-6195


Sonneveld, Pieter; Chanan-Khan, Asher; Weisel, Katja et al.

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial

JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 8. 2023 S. 1600-+


Bonifacius, Agnes; Lamottke, Britta; Tischer-Zimmermann, Sabine et al.

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors

JOURNAL OF CLINICAL INVESTIGATION. Bd. 133. H. 12. 2023


Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A. et al.

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

BLOOD ADVANCES. Bd. 7. H. 22. 2023 S. 7141-7150


Castven, Darko; Keggenhoff, Friederike; Stojkovic, Stojan et al.

Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase

JOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S536-S537




Bodmer, Nicole; Hecker-Nolting, Stefanie; Friedel, Godehard et al.

Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group

CANCER. 2023